Theriva Biologics Inc (TOVX)

[Citrati]

Have a great day. 'Leafman'
I am 2 time zones west of you. Current temp 28F and snow covering any rakeable leaves.

I think perhaps the biggest issues with Trimesta were twofold.
1. An underlying assumption that Rhonda Voskuhl was a so highly qualified researcher in the field that her years of work were ready for fruition.
2. Based on the above premise, IMO, SYN pushed hard with time and resources for Trimesta to become the fuller funding mechanism for SYN's other trials and products.

The gut biome products were always to be the biggest revenue drivers and flagship products but now the company must sail soley under their power.

I agree that 2017 will see recovery.
Seel is probably delving into this and will hopefully provide her thoughts on the future.
I follow too many to be truly knowledgeable and articulate on any one.
At my age, accumulation and preservation of capital are most important. Thus, I am trading more than many here, even among my favorites. SYN has printed green nicely for several years and I expect it to continue.

Best wishes for closing 2016 nicely Green and an even better 2017.
SYN